Vitaspring Biomedical (VSBC) Return on Capital Employed [ROCE] (2020 - 2022)
Vitaspring Biomedical's Return on Capital Employed [ROCE] was 68.86% in fiscal Q3 2023 (quarter ended Oct 31, 2022), up 34.67 percentage points from 34.19% a year earlier but down 12.00 percentage points from the prior quarter.
Powered by 
Analysis
Vitaspring Biomedical (VSBC) Return on Capital Employed [ROCE] (2020 - 2022) Analysis & Trends
For FY2022 (ended Jan 31, 2022), Return on Capital Employed [ROCE] at Vitaspring Biomedical came in at 709.26%, up 1150.69 percentage points from FY2021.
- In earlier fiscal years, Return on Capital Employed [ROCE] was -441.43% in FY2021.
- Quarterly Return on Capital Employed [ROCE] has moved between -23946.87% (fiscal Q4 2021) and 312.29% (fiscal Q4 2022) over five years.
- Compared with a year earlier, Return on Capital Employed [ROCE] has increased for four straight quarters, with an average year-over-year change of +4898.71 percentage points over the last five quarters.
- Per Business Quant data, VSBC's Return on Capital Employed [ROCE] in the three fiscal quarters before Q3 2023 was 80.85% (Q2 2023), 77.67% (Q1 2023) and 312.29% (Q4 2022).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 35.41% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 17.52% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 21.60% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 4.65% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 9.91% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 17.37% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -6.15% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 11.32% |
| 10 | Vitaspring Biomedical | 4.14 Mn | 4.12 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Oct 31, 2022 | 68.86% |
| Jul 31, 2022 | 80.85% |
| Apr 30, 2022 | 77.67% |
| Jan 31, 2022 | 312.29% |
| Oct 31, 2021 | 34.19% |
| Jul 31, 2021 | 10.87% |
| Apr 30, 2021 | -124.68% |
| Jan 31, 2021 | -23,946.87% |
| Apr 30, 2020 | -7.43% |
API Access
Vitaspring Biomedical Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=VSBC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "VSBC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=VSBC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();